The Singapore Clinical Research Institute (SCRI) was established in 2008 as the national academic clinical research organisation to enhance the standards of clinical research in Singapore. In 2021, it was appointed as the national coordinating body to implement the national clinical trial strategy and enhance clinical trial ecosystem.
PRECISE
Precision Health Research, Singapore (PRECISE) was established in 2020 as the central entity to coordinate a whole-of- government effort to implement Phase II of Singapore’s 10-year National Precision Medicine (NPM) strategy.
NHIC
The National Health Innovation Centre Singapore (NHIC) was established in 2014 as a nationally appointed Innovation and Enterprise Office that works with Public Healthcare Institutions across Singapore to identify, develop and commercialise promising clinical innovations to benefit patients and improve healthcare delivery.
STCC
The Singapore Translational Cancer Consortium (STCC) was established in 2020 as a nationally coordinated consortium to synergise cancer research capabilities in Singapore, bringing together unmatched basic, clinical and translational talent to create globally significant peaks of excellence in selected Asian cancers.
ACTRIS
The Advanced Cell Therapy and Research Institute, Singapore (ACTRIS) was established in 2020 to meet the increasing clinical demand of using cellular therapeutics to treat various life-threatening diseases. It facilitates the discovery, process development and manufacturing of cellular-based therapeutics across the broad spectrum of immunotherapy and regenerative medicine.
CADENCE
The Cardiovascular Disease National Collaborative Enterprise (CADENCE) was established in 2023 as a national clinical translational programme aimed at synergising cardiovascular research and technology capabilities across Singapore.
Results 1 – 12 of 12
Page 1 of 1
| Requisition No. | Title |
Date 
|
|
|---|---|---|---|